These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16029937)

  • 1. Vaginal polyps and hormones--is there a link? A case series.
    Sharma S; Albertazzi P; Richmond I
    Maturitas; 2006 Feb; 53(3):351-5. PubMed ID: 16029937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tibolone and risk of endometrial polyps: a prospective, comparative study with hormone therapy.
    Perez-Medina T; Bajo-Arenas J; Haya J; Sanfrutos L; Iniesta S; Bueno B; Castelo-Branco C
    Menopause; 2003; 10(6):534-7. PubMed ID: 14627862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
    Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
    Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma of the endometrium in patients treated with tibolone.
    Yazigi R; Sahid S; Contreras L; Rodriguez T
    Gynecol Oncol; 2004 May; 93(2):568-70. PubMed ID: 15099984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding with menopausal hormone therapy.
    Hickey M; Agarwal S
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):141-9. PubMed ID: 18977184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature.
    Pink D; Lindner T; Mrozek A; Kretzschmar A; Thuss-Patience PC; Dörken B; Reichardt P
    Gynecol Oncol; 2006 Jun; 101(3):464-9. PubMed ID: 16368128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Massive endometrial polyp after tamoxifen therapy.
    Divers MJ
    Br J Clin Pract; 1995; 49(5):275-6. PubMed ID: 7492471
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
    Dimitrakakis C; Keramopoulos D; Vourli G; Gaki V; Bredakis N; Keramopoulos A
    Climacteric; 2005 Dec; 8(4):342-51. PubMed ID: 16390769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
    Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
    Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial effects of tibolone in elderly, osteoporotic women.
    Ettinger B; Kenemans P; Johnson SR; Mol-Arts M; Van Os S; Seifert W; Verweij PJ; Cummings SR
    Obstet Gynecol; 2008 Sep; 112(3):653-9. PubMed ID: 18757665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 expression in endometrial polyps during menopause.
    Maia H; Correia T; Freitas LA; Athayde C; Coutinho E
    Gynecol Endocrinol; 2005 Dec; 21(6):336-9. PubMed ID: 16390782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endometrial cancers arising in polyps associated with tamoxifen use].
    Mbatsogo BA; Le Bouëdec G; Michy T; Bourdel N; Fouilloux G; Dauplat J
    Gynecol Obstet Fertil; 2005 Dec; 33(12):975-9. PubMed ID: 16321556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
    J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial polyps in pre-and postmenopausal women: factors associated with malignancy.
    Cohen I
    Maturitas; 2008 Jan; 59(1):99-100. PubMed ID: 18162338
    [No Abstract]   [Full Text] [Related]  

  • 15. Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen.
    McGurgan P; Taylor LJ; Duffy SR; O'Donovan PJ
    Maturitas; 2006 Jun; 54(3):252-9. PubMed ID: 16413707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone therapy and raloxifene reduce the coagulation inhibitor potential.
    Andresen MS; Eilertsen AL; Abildgaard U; Sandset PM
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):455-60. PubMed ID: 17581320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E; Libera H; Kimmig R; Forsting M
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tibolone and raloxifene on health-related quality of life and sexual function.
    Nijland EA; Weijmar Schultz WC; Davis SR
    Maturitas; 2007 Oct; 58(2):164-73. PubMed ID: 17870260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women.
    Chan SS; Tam WH; Yeo W; Yu MM; Ng DP; Wong AW; Kwan WH; Yuen PM
    BJOG; 2007 Dec; 114(12):1510-5. PubMed ID: 17995495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial cancer in polyps associated with tamoxifen use.
    Ramondetta LM; Sherwood JB; Dunton CJ; Palazzo JP
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):340-1. PubMed ID: 9988797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.